TerrAscend Corp provides update on sales licence application
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES/
TORONTO, March 9, 2018 /CNW/ - At the request of IIROC and as a result of the recent increase in market activity, TerrAscend Corp. (CSE: TER) ("TerrAscend" or the "Company") is providing an update on its sales licence application. Solace Health Inc. ("Solace"), a wholly-owned subsidiary of TerrAscend, has completed the final stages of its application for a sales licence that would permit it to sell dried cannabis from its production facility located in Mississauga, Ontario. Solace has responded to all of Health Canada's requests to date and is waiting for final approval.
TerrAscend is a Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of consumers. The Company provides support to medical consumers through its wholly-owned subsidiaries, Solace Health Inc., a licenced producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations and Terra Health Network Inc., a clinical support program and education platform led by healthcare professionals.
Please visit www.TerrAscend.com for more information about the Company.
Forward Looking Information
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements include, but are not limited to, the anticipated timing for closing of the Private Placement, and the anticipated use of proceeds of the Private Placement. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.